UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000012256
Receipt number R000014329
Scientific Title Pase II study of neoadjuvant chemotherapy with Docetaxel, Carboplatin, and Trastuzumab for operable Her2-positive breast cancer patients.
Date of disclosure of the study information 2013/11/09
Last modified on 2018/05/28 17:25:48

No. Disposal Last modified on Item of update
1 Insert 2013/11/09 16:19:16
2 Update 2018/05/28 17:25:48 Recruitment status